Pf Bacteriophage and Their Impact on Pseudomonas Virulence, Mammalian Immunity, and Chronic Infections.

Frontiers in Immunology
Patrick R. SecorPaul L. Bollyky

Abstract

Pf bacteriophage are temperate phages that infect the bacterium Pseudomonas aeruginosa, a major cause of chronic lung infections in cystic fibrosis (CF) and other settings. Pf and other temperate phages have evolved complex, mutualistic relationships with their bacterial hosts that impact both bacterial phenotypes and chronic infection. We and others have reported that Pf phages are a virulence factor that promote the pathogenesis of P. aeruginosa infections in animal models and are associated with worse skin and lung infections in humans. Here we review the biology of Pf phage and what is known about its contributions to pathogenesis and clinical disease. First, we review the structure, genetics, and epidemiology of Pf phage. Next, we address the diverse and surprising ways that Pf phages contribute to P. aeruginosa phenotypes including effects on biofilm formation, antibiotic resistance, and motility. Then, we cover data indicating that Pf phages suppress mammalian immunity at sites of bacterial infection. Finally, we discuss recent literature implicating Pf in chronic P. aeruginosa infections in CF and other settings. Together, these reports suggest that Pf bacteriophage have direct effects on P. aeruginosa infections and th...Continue Reading

References

Dec 8, 1990·Lancet·D P Casemore
Jan 1, 1988·Annual Review of Biophysics and Biophysical Chemistry·L A DayA Casadevall
Jan 1, 1966·Virology·K Takeya, K Amako
Dec 1, 1971·The Journal of Clinical Investigation·H D OchsR J Wedgwood
Sep 1, 1994·The Journal of Clinical Investigation·A E KochR M Strieter
Sep 1, 1993·The American Review of Respiratory Disease·A Buret, A W Cripps
Jan 1, 1993·The Journal of Pediatrics·S C FitzSimmons
Dec 1, 1995·American Journal of Respiratory and Critical Care Medicine·T L BonfieldM Berger
May 1, 1996·The American Journal of Physiology·S HashimotoJ Wiener-Kronish
Jul 14, 1998·Antimicrobial Agents and Chemotherapy·H IshidaH Kobayashi
Sep 17, 1998·The Journal of Clinical Investigation·H MatsuiR C Boucher
Feb 17, 1999·Biochimica Et Biophysica Acta·V IvanenkovA G Menon
May 21, 1999·Science·J W CostertonE P Greenberg
Feb 10, 2000·Acta Crystallographica. Section D, Biological Crystallography·L C WelshD A Marvin
Jan 3, 2001·The Journal of Infectious Diseases·J L BurnsB W Ramsey
May 9, 2001·The Journal of Pediatrics·G M NixonK Grimwood
Sep 7, 2001·Annual Review of Microbiology·W C Summers
Sep 21, 2001·Journal of Biomolecular NMR·M Zweckstetter, A Bax
Oct 26, 2001·Nature·M WhiteleyE P Greenberg
Dec 26, 2001·The Journal of Biological Chemistry·Minyong ChenRoss E Dalbey
Feb 23, 2002·Science·Cynthia B WhitchurchJohn S Mattick
Jul 27, 2002·Annual Review of Microbiology·P StoodleyJ W Costerton
Jul 18, 2003·Journal of Bacteriology·Jeremy S WebbStaffan Kjelleberg
Sep 6, 2003·American Journal of Respiratory and Critical Care Medicine·Jin-Hwa LeeHaibo Zhang
Nov 1, 1964·The Journal of Experimental Medicine·R ARONOWM ARONSON
Oct 7, 2003·Annual Review of Microbiology·Matthew R Parsek, Pradeep K Singh
Oct 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Algirdas J JesaitisZbigniew Lewandowski
Oct 15, 2003·Clinical Microbiology Reviews·Timothy Andrews, Kathleen E Sullivan
Dec 25, 2003·Burns : Journal of the International Society for Burn Injuries·Edward E TredgetSarvesh Logsetty
Jul 1, 2004·Molecular Microbiology·Carlos CanchayaHarald Brüssow
Aug 4, 2004·Journal of Molecular Biology·David S ThiriotStanley J Opella
Oct 9, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Benjamin A LipskyUNKNOWN Infectious Diseases Society of America
Nov 18, 2004·Journal of Bacteriology·Jeremy S WebbStaffan Kjelleberg
Dec 4, 2004·Nature Medicine·Stuart B Levy, Bonnie Marshall

❮ Previous
Next ❯

Citations

Jul 7, 2020·PHAGE : Therapy, Applications, and Research·Elizabeth B BurgenerPaul L Bollyky
Oct 3, 2020·Nanomaterials·Jan Paczesny, Krzysztof Bielec
Jul 14, 2020·Genome Biology and Evolution·Krzysztof FiedorukRobert Bucki
Dec 15, 2020·Current Opinion in Biotechnology·Christiaan R de VriesPaul L Bollyky
Mar 18, 2021·NPJ Biofilms and Microbiomes·Karishma BishtCatherine A Wakeman
Mar 19, 2021·Advances in Wound Care·Chandan K Sen
Jul 2, 2021·Environmental Microbiology Reports·Sandhya Rai, Amod Kumar
Aug 10, 2021·EMBO Molecular Medicine·Ameneh KhatamiJonathan R Iredell
Sep 15, 2021·Open Biology·Sari MäntynenSamuel L Díaz-Muñoz

❮ Previous
Next ❯

Methods Mentioned

BETA
phage display
NMR

Software Mentioned

MAFFT
FastTree
FigTree

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.